FMP
Evotec SE
EVT.DE
XETRA
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
9.64 EUR
-4.54 (-47.1%)
About
ceo
Dr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D.
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.evotec.com
exchange
XETRA
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company wa...
CIK
N/A
ISIN
DE0005664809
CUSIP
D1646D105
Address
Essener Bogen 7
Phone
49 40 560 81 0
Country
DE
Employee
4,952
IPO Date
Nov 12, 1999
Summary
CIK
-
Exchange
XETRA
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
D1646D105
ISIN
DE0005664809
Country
DE
Price
9.64
Beta
0.99
Volume Avg.
706.97k
Market Cap
1.71B
Shares
-
52-Week
8.52-24.44
DCF
11.63
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-9.36
P/B
-
Website
https://www.evotec.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest EVT.DE News
It looks like there's no news available.
